TAM
ABMD

Tiverton Asset Management’s Abiomed Inc ABMD Stock Holding History

Tiverton Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$302K Sell
1,699
-485
-22% -$105K 0.01% 496
2019
Q2 		$569K Buy
2,184
+543
+33% +$144K 0.02% 355
2019
Q1 		$469K Buy
1,641
+1,004
+158% +$334K 0.02% 350
2018
Q4 		$207K Hold
637
– – 0.01% 304
2018
Q3 		$286K Hold
637
– – 0.01% 292
2018
Q2 		$261K Buy
+637
New +$231K 0.01% 292

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Tiverton Asset Management's ABMD Position: Q3 2019 in Review

Tiverton Asset Management reduced its Abiomed Inc (ABMD) stake by 22% in Q3 2019, selling an estimated $105K and leaving 1,699 shares worth $302K. The position accounts for 0.01% of the portfolio, ranked #496.

Tiverton Asset Management first reported a position in ABMD in Q2 2018 and has held it in 6 quarters since. The position peaked at $569K in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

  • Tiverton Asset Management held 1,699 shares of Abiomed Inc worth $302K as of Q3 2019.
  • Tiverton Asset Management sold 485 Abiomed Inc shares in Q3 2019, an estimated $105K.
  • Abiomed Inc made up 0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #496 holding.
  • Tiverton Asset Management first reported a position in Abiomed Inc in Q2 2018 and has held it in 6 quarters since.
  • Tiverton Asset Management's Abiomed Inc position peaked at $569K in Q2 2019.
  • 443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.